STOCKWATCH
·
Pharmaceuticals
New Launch18 Jun 2025, 10:27 am

Sigachi Industries Ltd Inaugurates State-of-the-art R&D Center in Hyderabad

AI Summary

Sigachi Industries Ltd, a leading player in the pharmaceutical industry, has officially opened its new R&D Center in Hyderabad. The advanced facility is designed to accelerate the development of critical APIs and enhance in-house analytical capabilities, strengthening API development and regulatory alignment, fueling pipeline growth, and focusing resources effectively. The R&D Center is a strategic asset that will significantly enhance development capabilities and enable swift responses to market needs.

Key Highlights

  • Sigachi Industries Ltd has inaugurated a state-of-the-art R&D Center in Hyderabad.
  • The facility is designed to accelerate API development and enhance analytical capabilities.
  • The R&D Center will strengthen API development and regulatory alignment, fuel pipeline growth, and focus resources effectively.
  • The investment of up to USD 1 million will support priority APIs and complex intermediates.
  • The R&D Center is a strategic asset that will significantly enhance development capabilities and enable swift responses to market needs.
SIGACHI
Pharmaceuticals
Sigachi Industries Ltd

Price Impact